Skip to main content

Research Repository

Advanced Search

Immunohistochemical Investigation into Protein Expression Patterns of FOXO4, IRF8 and LEF1 in Canine Osteosarcoma

de Brot, Simone; Cobb, Jack; Alibhai, Aziza A.; Jackson-Oxley, Jorja; Haque, Maria; Patke, Rodhan; Harris, Anna E.; Woodcock, Corinne L.; Lothion-Roy, Jennifer; Varun, Dhruvika; Thompson, Rachel; Gomes, Claudia; Kubale, Valentina; Dunning, Mark D.; Jeyapalan, Jennie N.; Mongan, Nigel P.; Rutland, Catrin S.

Immunohistochemical Investigation into Protein Expression Patterns of FOXO4, IRF8 and LEF1 in Canine Osteosarcoma Thumbnail


Authors

Simone de Brot

Jack Cobb

Aziza A. Alibhai

Jorja Jackson-Oxley

Maria Haque

Rodhan Patke

Dhruvika Varun

Rachel Thompson

Claudia Gomes

Valentina Kubale

NIGEL MONGAN nigel.mongan@nottingham.ac.uk
Professor of Oncology



Abstract

Osteosarcoma (OSA) is the most common type of primary bone malignancy in people and dogs. Our previous molecular comparisons of canine OSA against healthy bone resulted in the identification of differentially expressed protein-expressing genes (forkhead box protein O4 (FOXO4), interferon regulatory factor 8 (IRF8), and lymphoid enhancer binding factor 1 (LEF1)). Immunohistochemistry (IHC) and H-scoring provided semi-quantitative assessment of nuclear and cytoplasmic staining alongside qualitative data to contextualise staining (n = 26 patients). FOXO4 was expressed predominantly in the cytoplasm with significantly lower nuclear H-scores. IRF8 H-scores ranged from 0 to 3 throughout the cohort in the nucleus and cytoplasm. LEF1 was expressed in all patients with significantly lower cytoplasmic staining compared to nuclear. No sex or anatomical location differences were observed. While reduced levels of FOXO4 might indicate malignancy, the weak or absent protein expression limits its primary use as diagnostic tumour marker. IRF8 and LEF1 have more potential for prognostic and diagnostic uses and facilitate further understanding of their roles within their respective molecular pathways, including Wnt/beta-catenin/LEF1 signalling and differential regulation of tumour suppressor genes. Deeper understanding of the mechanisms involved in OSA are essential contributions towards the development of novel diagnostic, prognostic, and treatment options in human and veterinary medicine contexts.

Citation

de Brot, S., Cobb, J., Alibhai, A. A., Jackson-Oxley, J., Haque, M., Patke, R., …Rutland, C. S. (2024). Immunohistochemical Investigation into Protein Expression Patterns of FOXO4, IRF8 and LEF1 in Canine Osteosarcoma. Cancers, 16(10), Article 1945. https://doi.org/10.3390/cancers16101945

Journal Article Type Article
Acceptance Date May 18, 2024
Online Publication Date May 20, 2024
Publication Date May 20, 2024
Deposit Date Jun 10, 2024
Publicly Available Date Jun 12, 2024
Journal Cancers
Electronic ISSN 2072-6694
Publisher MDPI
Peer Reviewed Peer Reviewed
Volume 16
Issue 10
Article Number 1945
DOI https://doi.org/10.3390/cancers16101945
Public URL https://nottingham-repository.worktribe.com/output/35159716
Publisher URL https://www.mdpi.com/2072-6694/16/10/1945

Files





You might also like



Downloadable Citations